Figure 3

Relative distribution of (A) FOXP3⁺ cells in total CD4⁺ PBMC (B) CD25⁺ cells in total CD4⁺FOXP3⁺PBMC and (C) CD25⁺ cells in total CD4⁺FOXP3^- PBMC between patients (n = 19) and controls (n = 10).